Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells

Chun-Yu Liu, Ling‐Ming Tseng, Ka-Yi Lau et al.|PLoS ONE|2017

Cited by 65